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Abstract
Background: Idiopathic inflammatory bowel disease and 
microscopic colitis are distinct entities; however, some 
clinical features overlap. 
Aims: To identify if these alternative diagnoses may 
direct clinical therapy more effectively.
Methods: We describe seven patients who had 
intermittent phases of either inflammatory bowel disease 
or microscopic colitis in at least two separate occasions 
with matching clinical and endoscopic pictures. 
Results: Diarrhea was the presenting symptom in all 
cases. In two of seven cases, the initial diagnosis was 
microscopic colitis, and in five cases it was inflammatory 
bowel disease. Addition of medication specific to 
diagnosis had resulted in improvement in six out of 
seven cases. Among the seven patients we reported, 
three had used nonsteroidal antiinflammatory drugs, 
a well-known trigger, before the onset of microscopic 
colitis. 
Conclusions: Inflammatory bowel disease and 
microscopic colitis are distinct clinicopathologic entities 
that may coexist in the same patient. Triggering factors 
for microscopic colitis in the general population can also 
be the culprit in inflammatory bowel disease patients. 
Microscopic colitis may present as an epiphenomenon 
which is superimposed on predisposing inflammatory 
bowel disease patients. A thorough synthesis of all clinical, 
medication, endoscopic, radiology, and pathological data 
is crucial in these patients.
Key words: Inflammatory bowel disease; Crohn 
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INTRODUCTION
Idiopathic inflammatory bowel disease (IBD) mainly 
includes ulcerative colitis and Crohns disease, with unique 
clinical, endoscopic, and histologic features. Microscopic 
colitis (MC) consists of two entities, collagenous colitis 
and lymphocytic colitis, which are clinically characterized 
by nonbloody, watery diarrhea and an essentially normal 
endoscopy. IBD and MC are distinct entities; however, 
some clinical features overlap. Interestingly, a small 
number of cases with co-occurrence of IBD and MC at 
different periods in the same patient during the clinical 
course of disease have been reported.[4. 6, 8, 12 ]To date, the 
relationship between IBD and MC in this patient group is 
largely unclear. Some authors suggested that MC might 
be part of the spectrum of IBD, given the lack of other 
compounding factors (infection or other autoimmune 
condition) in their IBD patients with MC episodes.[8] In 
this paper we present a case series that includes seven 
patients who had either IBD or MC at different stages of 
their disease progression. The occurrence of MC and IBD 
with regard to the clinical and endoscopic context was 
fully analyzed to address their relationship.
MATERIALS AND METHODS
A retrospective search of the Laboratory Information 
Systems at Indiana University Health and Washington 
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University was performed for the period between January 
2000 and September 2013. This study was approved by 
the Institutional Review Boards. Patients who had distinct 
diagnoses of both IBD and MC in at least two separate 
occasions were identified. The relevant clinical history, 
endoscopy reports, and surgical pathology slides for 
these patients were retrieved and reviewed. Cases were 
included if a patient had biopsy or resection specimens 
that showed histologic features of either MC or IBD at 
two distinct time points. Cases with inadequate clinical or 
endoscopic history or questionable histologic diagnoses 
were eliminated. A total of seven cases met the study 
criteria and were included.
The pathology specimens were evaluated by each 
pathologist (HO, JL, RW, and IN) without knowing 
the clinical history or prior diagnosis. The histological 
features, including architectural distortion, intraepithelial 
lymphocytosis, subepithelial collagen table thickening, 
increased inflammatory cells within the lamina propria, 
presence of epithelial injury, cryptitis, and crypt 
abscesses, were evaluated in each individual case by each 
pathologist. The histopathological changes were then 
correlated with the clinical and endoscopic findings. The 
diagnoses of IBD and MC were made only on occasions 
in which the clinical symptoms and endoscopic and 
histologic findings were compatible with the respective 
disease stage. Disagreements among investigators were 
resolved by consensus opinion.
In all cases in which a diagnosis of MC was made, 
the endoscopic picture was normal or near normal, and 
nonbloody diarrhea or worsening of diarrhea was the main 
presenting symptom. Ulcerative colitis and Crohns disease 
were accompanied by varying degrees of gross endoscopic 
changes that included increased vascular pattern, erythema 
of the mucosa and ulceration, and clinical intestinal and/or 
extraintestinal symptoms. 
CASE REPORT
Patient 1
A 40-year-old female presented with diarrhea alternating 
with constipation for one year at an outside facility. Her 
endoscopy was reported to show aphthous ulcers and 
the pathology revealed chronic inflammatory changes 
(slides not available for review). An initial diagnosis of 
Crohns disease was suspected. The patient did improve 
on donnatal. A followup colonoscopy one month later 
did not reveal any endoscopic abnormalities. However, 
the biopsies from the colon revealed lymphocytic colitis 
(Figure 1A and 1B; Table 1), with no evidence of chronic 
or active colitis or architectural disarray. An upper 
endoscopy was performed at the same time that revealed 
longitudinal ulcers in the gastric body and several small 
erosions in the stomach and duodenum, confirmed 
microscopically to be consistent with acute inflammation 
and ulceration. The patient was started on asacol with only 
partial improvement.
She experienced worsened diarrhea and an anal fissure 
one year later; a colonoscopy revealed congested granular 
mucosa suggestive of IBD. The biopsies showed chronic 
active colitis with cryptitis and crypt abscesses consistent 
with IBD (Figure 1C and 1D). Budesonide and entocort 
were added to asacol at this point which proved effective 
in controlling the symptoms. Three years later, the patient 
had more or less controlled diarrhea, but experienced 
intermittent epigastric pain, nausea, and vomiting. A 
colonoscopy was performed and showed granular mucosa 
in the left colon. Interestingly, a diagnosis of collagenous 
colitis was rendered on microscopic examination (Figure 
1E and 1F). The mucosal architecture appeared to be 
preserved; however, thickened subepithelial collagen table 
was found with increased intraepithelial lymphocytes. 
The patient resumed asacol and entocort with improved 
response to diarrhea. Nexium was added to control the 
recent upper gastric symptoms.
Figure 1
Episodes of Inflammatory Bowel Disease and 
Microscopic Colitis in Patient 1. 
A (low power) and  B  (high power),  Phase 1: 
Lymphocytic colitis. Biopsy showing intraepithelial 
lymphocytosis ,  epi thel ial  injury,  and increased 
inflammatory infiltrate in the lamina propria without 
mucosal architectural distortion. C and D, Phase 2: 
Inflammatory bowel disease. Biopsy showing chronic 
active colitis with architectural distortion and cryptitis. 
E and F, Phase 3: Collagenous colitis. Biopsy showing 
preserved colonic architecture with intraepithelial 
lymphocytosis, epithelial injury, and thickened subepithelial 
collagen table deposition highlighted in trichrome stain (F).
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Table 1
Clinical Characteristic of Patients
Case 1 2 3 4 5 6 7
Age at the time of 
first Phase (y)
40 67 50 60 39 49 58
Gender F F F M F F F
Other history chronic back pain
meralgia 
parasthesia,
ischemic heart 
disease
none
hypertension, 
seasonal allergy, 
gastroesophageal reflux, 
bronchospasm
choledocho-
lithiasis
squamous cell 
carcinoma of 
anal canal 
enteropathic arthritis, 
breast cancer, 
depression
History of smoking no no no yes, 25-pack/year no no yes, 8-pack/y
        
Fi
rs
t P
ha
se
Phase microscopic colitis microscopic colitis IBD (UC) IBD (UC) IBD (CD) IBD (CD) IBD (CD)
Pathology lymphocytic colitis lymphocytic colitis CAC CAC patchy CAC normal focal/patchy CAC
Duration 1 years 2 years 2 years 13 years 10 years 18 years 15 years
Endoscopic normal colon normal colon chronic colitis chronic colitis chronic colitis remission patchy colitis
Clinical diarrhea acute nonbloody diarrhea diarrhea episodes of diarrhea
episodes of 
diarrhea
episodes of 
diarrhea remission
Effective Medication none none asacol asacol
imuran / 
entocort / 
azathioprine
remicade / 
cymbalta
humira / 6MP /  
MTX / sulfasalazine
Noneffective 
medication asacol imodium none remicade/prednisone none imuran none
        
Se
co
nd
 P
ha
se
Phase IBD (UC) IBD (UC) microscopic colitis microscopic colitis
microscopic 
colitis
microscopic 
colitis microscopic colitis
Pathology CAC patchy CAC collagenous colitis collagenous colitis 
collagenous 
colitis
collagenous 
colitis lymphocytic colitis
Duration 3 years 2 years 4 years 6 months 2 years 1 year 4 weeks
Endoscopic N/A suggestive left sided UC normal colon colitis
Patchy 
erythema remission normal colon 
Clinical
worsened 
diarrhea, anal 
fissure
bright red blood per 
rectum
cramping and 
diarrhea refractory diarrhea
increasing 
diarrhea
weight loss, 
loose stools watery diarrhea
Effective Medication
asacol / 
budesonide / 
entocort
asacol asacol none entocort entocort none
Noneffective 
medication N/A N/A N/A
prednisone / remicade / 
asacol N/A  N/A
humira / 6MP /  
MTX / sulfasalazine
        
Th
ird
 P
ha
se
Phase microscopic colitis N/A N/A N/A IBD (CD) N/A N/A
Pathology collagenous colitis  
CAC with 
granuloma  
Duration 5 years  1 year  
Endoscopic granular mucosa in left colon  
extensive mild 
colitis  
Clinical
intermittent 
epigastric pain, 
N&V
 diarrhea  
Effective Medication asacol / entocort / nexium  
Imuran / 
entocort / 
azathiprine
 
Noneffective 
medication none  none  
Note. CAC, chronic active colitis; CC, collagenous colitis; CD, Crohns disease; IBD, inflammatory bowel disease; LC, lymphocytic colitis; 
N/A, not applicable; N&V, nausea and vomiting; UC, ulcerative colitis; 6MP, mercaptopurine; MTX, methotrexate .
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Patient 2
A 67-year-old female presented with lower quadrant pain 
for 3 months. Her medication history was significant 
for norvasc for hypertension, lexapro and xanax for 
depression and anxiety, and gabapentin for meralgia 
paresthetica. A colonoscopy showed an essentially 
normal colonic mucosa with no evidence of polyps or 
diverticulosis. Moderate sized internal hemorrhoids were 
noted on retroflexion of the endoscope in the rectum. No 
biopsy was performed. She developed acute nonbloody 
diarrhea 5 months later and colonoscopy was still normal 
despite poor colonoscopy prep. At this time biopsies 
showed lymphocytic colitis with no evidence of chronic 
active colitis. Imodium was tried without satisfactory 
response. Approximately two years later, the patient 
presented with bloody diarrhea and a colonoscopy showed 
changes consistent with ulcerative colitis characterized 
by congested erythematous mucosa with a prominent 
vascular pattern. Histologically, there was a dense chronic 
inflammatory cell infiltrate in the lamina propria including 
numerous eosinophils with minimal architectural disarray. 
Patchy crypt abscesses were identified. There was 
mild increase in intraepithelial lymphocytes within the 
crypts but relatively sparing the surface epithelium. The 
subepithelial collagen band was normal. No granulomas 
or dysplasia were seen. These findings were those of IBD 
rather than lymphocytic colitis. Asacol was started with 
remission of symptoms.
Patient 3
A 50-year-old female presented with a chief complaint of 
nonbloody chronic diarrhea for approximately two years. 
She did not have any other significant medical issues. She 
associated the onset of the diarrhea with her dietary switch 
to a vegetarian diet. Her bowel movements changed to 
more frequent movements of about twice a day; however, 
for the last 6 months she developed approximately ten 
movements per day without mucous, blood, or oil. These 
were accompanied by lower quadrant cramping and 
pressure. A colonoscopy was performed and revealed 
diffuse areas of congested, erythematous, and vascular 
pattern–decreased mucosa from rectum to descend colon. 
The biopsy revealed patchy chronic active colitis with 
architectural disarray consistent with IBD. No granulomas 
or other abnormalities were seen. She was started on 
asacol 400mg, TID, with significant improvement. 
Three years later, the patient relapsed with cramping 
and increased diarrhea. Another colonoscopy was 
scheduled which revealed an essentially normal colon. 
Biopsy revealed preserved architecture with no evidence 
of active inflammation. There was focally thickened 
subepithelial collagen table deposition, increased 
intraepithelial lymphocytosis, associated epithelial 
damage, and lymphocytic infiltration of the lamina 
propria. Given these findings, a diagnosis of collagenous 
colitis was rendered. The patient continued asacol therapy 
for four years with occasional bouts of cramping and 
diarrhea.
Patient 4
A 60-year-old man presented for a 13-year history of 
ulcerative colitis. He was unable to wean from prednisone 
with persistent diarrhea consisting of five to ten bowel 
movements per day and decreased rectal tone. His other 
medical problems included hypertension, seasonal 
allergies, gastroesophageal reflux disease, bronchospasm, 
and a previous 25-pack per year smoking history. He 
initially had a diagnosis of ulcerative proctitis and was 
treated with asacol with good response for 10 years. Three 
years later, he had worsening clinical symptoms, thus 
remicade in addition to the prednisone was given with no 
response. A trial of azathioprine followed which resulted 
in transaminitis. Canasa and hydrocodone suppositories 
were also not successful. He continued to use 40 mg 
of oral prednisone daily. A flexible sigmoidoscopy 
performed at that time showed continuous disease from 
proximal colon to the rectum. Biopsies showed chronic 
active inflammation with foci of cryptitis, crypt abscesses, 
basal plasmacytosis, and prominent architectural disarray 
compatible with ulcerative colitis. No granulomas or 
dysplasia were identified.
The most recent colonoscopy, performed a year before 
colectomy, showed diffuse inflammation involving 
the descending colon to the rectum. The inflammation 
was mild in the distal descending colon and moderate 
in the sigmoid colon and rectum. Biopsies performed 
at an outside facility were reported to show diffuse 
chronic inactive colitis with architectural disarray and a 
patchy thickened subepithelial collagen band only in the 
ascending and sigmoid colon. No change in his medical 
treatment was made during this period.
In light of his persistent refractory symptoms and 
decreased rectal tone, definitive treatment by total 
colectomy and ileostomy were undertaken. Histologic 
sections showed increased intraepithelial lymphocytes as 
well as a markedly thickened subepithelial collagen band 
throughout the entire specimen. No architectural disarray, 
cryptitis, or crypt abscesses were seen. Thus, a diagnosis 
of collagenous colitis was rendered. His postoperative 
period was complicated by bowel evisceration and stomal 
prolapse that required surgical intervention. One year after 
surgery, he continues to do well with his stoma. 
Patient 5
A 39-year-old female has a history of Crohns disease that 
was somewhat stable on medications. During a period of 
10 years she appeared to have a more or less stable disease 
with episodes of increasing symptoms occurring every 
several months. Her main medication was imuran 200 
mg a day; however, remicade, azathioprine, and entocort 
had been added at various times. She seemed to respond 
best to steroids during her worsened episodes. She did not 
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have any extraintestinal symptoms. Both her endoscopic 
and pathologic pictures were consistent throughout the 
10-year period. Her colonoscopies were consistent with 
Crohns disease in remission with localized erythematous 
areas and vascular pattern noted in the sigmoid colon 
and rectum. Scarring of the sigmoid colon was more 
prominent at approximately 7 years post-presentation. 
The pathology consistently showed a varying degree of 
architectural distortion with occasional minimal to mild 
activity that corresponded to clinical presentations. 
She then developed increased bowel movements of 
nonbloody diarrhea with cramping and was unable to 
stay in remission despite steroids. Clostridium difficile 
was suspected, although no evidence was found. The 
colonoscopy appeared normal with only a few patches 
of erythema but no granularity. Histologically, the 
subepithelial collagen layer was increased in thickness and 
was accompanied by a mild intraepithelial lymphocytosis 
with increased inflammatory cells in the lamina propria. 
These findings were most consistent with collagenous 
colitis. She started entocort and responded dramatically 
for 2 years. 
Unfortunately, she developed bloody diarrhea 2 years 
later that required steroids. The diarrhea would remit every 
time she was tapered off the steroids. Azathoprine was 
added and she was able to eventually go back in remission. 
Colonoscopy performed after remission showed patchy 
inflammation in the bowel. The biopsies confirmed the 
colonoscopic findings and showed chronic minimally 
active colitis and proctitis with no granulomata. There was 
no thickening of the subepithelial collagen table noted.
Patient 6
A 49-year-old female presented an extensive history 
of Crohns disease for more than 18 years. She suffered 
extraintestinal manifestations, such as aphthous stomatitis, 
persistent chronic sinusitis, and eye symptoms, which 
presented approximately 10 years after initial diagnosis 
and was responsive to remicade. Her gastrointestinal 
disease was initially controlled with remicade and 
cymbalta with good response and only rare episodes of 
increased diarrhea, which was successfully treated with 
titration of remicade. 
Colonoscopies done during that period revealed 
extensive colitis in remission. Throughout the entire 
period of 18 years, colonoscopies consistently showed 
scattered pseudopolyps with scarred vascular pattern–
decreased mucosa throughout the entire colon. She 
developed an anal fissure almost 17 years since her 
diagnosis. Pathologically, chronic inactive colitis was 
the predominant histologic diagnosis throughout that fits 
the endoscopic and clinical pictures. Occasionally, focal 
activity was noted, and scattered tubular adenomas were 
also found. 
She most recently presented with a complaint of 
weight loss and a painful digital exam. This was attributed 
to the history of an anal fissure. A colonoscopy procedure 
was performed and a mass was found in the rectum. 
The remainder of the colon had the usual appearance of 
scarred vascular pattern–decreased mucosa with scattered 
pseudopolyps. Pathology revealed two unexpected 
diagnoses for this patient: an anal poorly differentiated 
squamous cell carcinoma and collagenous colitis. Biopsies 
from the rectal mass revealed poorly differentiated 
basaloid-type squamous cell carcinoma that was positive 
for p63 and negative for synaptophysin and chromogranin 
A by immunostaining. The remainder of the colon showed 
preserved villous architecture with thickened subepithelial 
collagen layer, increased intraepithelial and lamina propria 
lymphocytes, and some endothelial damage. There was 
no evidence of chronic or active colitis, and there was no 
evidence of granuloma. She received chemoradiation for 
the anal carcinoma that was determined clinically to be a 
T2N0M0 with excellent response. There was no evidence 
of residual disease on subsequent PET scan. Her diagnosis 
of collagenous colitis was accompanied by diarrhea that did 
not respond to remicade infusions. Subsequently, entocort 
was added to her therapy providing appropriate relief.
Patient 7
A 58-year-old woman with a more than 15-year history of 
Crohn disease, whose clinical course was complicated by 
enteropathic arthritis, presented with a 4-week history of 
watery diarrhea occurring up to six to seven times per day. 
Many years prior, she had a diagnosis of ulcerative colitis, 
which was revised to Crohns disease. Her other medical 
problems included a history of breast cancer treated with 
a mastectomy and adjuvant chemotherapy as well as 
depression. She is a current eight-pack per year smoker. 
Her bowel disease had been in full remission on humira, 
6-mercaptopurine, methotrexate, and sulfasalazine prior to 
this present episode. The patient did not report any melena 
or hematochezia. Stool studies, including an examination 
for ova and parasites, Clostridium difficile toxin, and 
culture were negative. Colonoscopy was performed and 
showed an ulcer in the ascending colon and 4–6mm 
polyps in the descending colon. Biopsies demonstrated 
severe chronic active colitis in the right colon and focal 
activity in the left colon. Both biopsies had evidence 
of chronic mucosal injury with architectural disarray, 
including focal Paneth cell metaplasia on the left sided 
biopsies. No dysplasia or granulomas were seen. 
Two years later, another colonoscopy was performed 
which showed two sessile polyps in the rectum and 
normal colonic mucosa throughout. Biopsies from the 
right and left colon as well as the rectosigmoid colon 
showed increased intraepithelial lymphocytes with some 
surface damage. Paneth cell metaplasia was again noted 
in the left colon but no active inflammation, granulomas, 
or architectural disarray was identified. A diagnosis of 
lymphocytic colitis was rendered. In an effort to eliminate 
a possible medication-related effect, the patient was asked 
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to taper sertraline that was previously prescribed. At 
followup, she continues to be symptomatic.
DISCUSSION
IBD and MC are two well recognized clinicopathologic 
entities. However, the etiology and the pathogenesis of 
either IBD or microscopic colitis remain incompletely 
understood. Recent studies suggest that a complex 
interplay between the gut microbiome and genetic 
susceptibility play a role in IBD.[9] More than 160 
loci have been associated with the susceptibility to 
IBD.[9] This genetic susceptibility may be due to an altered 
immune response to the gut flora, allowing the host to 
be susceptible to specific gut bacteria and increasing 
the risk of IBD. Other factors that may contribute to 
the pathogenesis of IBD include genetic, infectious, 
physiological, dietary, and immunological factors.[10, 15] 
The etiology of MC is also multifactorial. Lymphocytic 
colitis has a known association with autoimmune disorders 
including celiac disease, rheumatoid arthritis, thyroiditis, 
and type I diabetes mellitus.[3] A wide variety of drugs, 
including nonsteroidal antiinflammatory drugs and proton 
pump inhibitors, selective serotonin reuptake inhibitors, and 
statins, are considered possible triggers.[3, 11, 14] 
Interestingly, more evidence supports shared risk 
factors between both IBD and MC. For example, 
smoking is a risk for collagenous colitis as well as Crohns 
disease.[1, 3, 13] Like IBD, there is evidence that the 
pathogenesis of MC may be secondary to genetic and 
immunological predisposition to mucosal insults by 
bacteria, although only a limited number of “family 
clusters” in MC have been reported. Some family members 
of MC patients have been reported to have Crohns disease, 
ulcerative colitis, and microscopic colitis within the 
family, emphasizing the genetic relationship between these 
diseases.[5] Interestingly, in a study by Olesen et al, 7% of 
patients with lymphocytic colitis have a family history of 
either ulcerative colitis or Crohns disease.[7]
However, the incidence of both MC and IBD in the 
same patient is rare, generally puzzling clinicians and 
pathologists. Goldstein et al described focal and patchy 
lymphocytic colitis and collagenous colitis in biopsies 
from four patients of Crohns disease, suggesting a 
temporal precedence of MC before the presentation 
of Crohns disease.[7] On the contrary, another study by 
Jegadeesan et al demonstrated six patients with IBD 
who later developed MC.[8] A few other papers addressed 
the metachronous occurrence of collagenous colitis 
and IBD. In two papers, collagenous colitis succeeded 
ulcerative colitis or Crohns disease, while others reported 
precedence of collagenous colitis.[2, 4, 6, 12] These papers 
are summarized in Table 2. Although these studies 
emphasized on the occurrence of MC either before or after 
IBD, a detailed correlation among pathologic, endoscopic, 
and clinical course regardless of the order between IBD and 
MC has not been closely studied. In this paper, we focus 
on the occurrence of MC and IBD at various timeframes 
and with regard to the clinical and endoscopic context to 
fully evaluate this relationship. It appears that lymphocytic 
colitis occurrence likely preceded that of IBD (Cases 1 and 
2), while collagenous colitis succeeded it (Cases 1, 3, 4, 
5, and 7). In one case, the patient was initially diagnosed 
with lymphocytic colitis, then Crohns disease, and finally 
collagenous colitis (Case 1), highlighting the complex 
relationship between these entities. This is the first time, 
to our knowledge, that multifaceted compound transition 
between IBD and MC has been reported. The transition 
from one phase to the other was often accompanied 
clinically by worsening diarrhea or by resistance to 
the treatment that was used in the former phase. The 
appropriate switch in therapy often resulted in improvement 
of symptoms, suggesting that these alternative diagnoses 
(particularly those of MC) are real co-occurrences rather 
than nonspecific pathomorphologic findings.
Table 2
Reported Cases of Intermittent Inflammatory Bowel 
Disease and Microscopic Colitis
Reports Case number
Initial 
episode
Second 
episode
Third 
episode
Osman (current) 7
2 LC
3 CD
2 UC
2UC
2 CC and 1 LC
2 CC
1 CC
1 CD
Chandratre4 1 CC CD
Bohr2 3 CD CC
Pokorny12 2 CC UC
Giardiello6 1 CC UC
Jegadssen8 6 UC MC
Goldstein7 4 CD MC
Note. IBD, inflammatory bowel disease; MC, microscopic colitis; 
UC, ulcerative colitis; CC, collagenous colitis.
Taken together all cases we reported here along 
with a few other prior reports, it appears that MC may 
be accompanying the diagnosis of IBD either before or 
after. Are the episodes of IBD and MC in one patient 
unrelated? Or do these two events belong to the same 
pathologic process? Previous reports suggested that 
MC might be a part of the spectrum of IBD, given the 
lack of other compounding factors (infection or other 
autoimmune condition) in their IBD patients with 
MC episodes.[8] However, the etiology of MC in these 
IBD patients could be equally complex. Among the 
seven patients we reported, three (Cases 1–3) had used 
nonsteroidal antiinflammatory drugs (NSAID, asacol), 
a well-known trigger, before the onset of MC. NSAID 
usage was also reported in two of six patients with IBD 
who subsequently developed MC in a previous study.[8]
MC may, therefore, present as an epiphenomenon which 
is superimposed on predisposed individual with other 
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well-established disease processes including IBD. MC 
might be associated with a certain drug in susceptible 
IBD patients due to an idiosyncratic reaction. Thus, the 
co-occurrence of IBD and MC may or may not belong 
to the same disease. The etiology of each patient may be 
different depending on the variable genetic background, 
treatment regimen, and peculiar reaction. 
In practice, information of drugs is frequently 
overlooked. In addition, it is not a surprise that other 
related information, including autoimmune disease 
and infection, is not well documented or available for 
pathologists before making a diagnosis of MC. Therefore, 
we recommend, for each patient with intermittent episodes 
of IBD and MC, a thorough synthesis of all data including 
clinical symptoms, medication, endoscopy, radiology, and 
pathology. A close collaboration between the clinicians 
and pathologists is of paramount importance to reach an 
accurate diagnosis. 
In summary, IBD and MC are two distinct clinical 
entities that may coexist in the same patient. Identification 
of these alternative diagnoses may direct clinical therapy 
more effectively. MC may present as an epiphenomenon 
which is superimposed on susceptible IBD patients. 
Triggering factors for MC in the general population can 
also be the culprit in IBD patients. A thorough synthesis 
of all clinical, medication, endoscopic, radiology, and 
pathological data is crucial in these patients.
ACKNOWLEDGEMENTS
We acknowledge Tracey Bender and Amy Thomasson for 
their assistance with preparing this manuscript and Fredrik 
Skarstedt for his efforts in the preparation of figure.
JL and IN constructed the conception and design of 
the study. HO, RW, and RF acquired the data. HO drafted 
the article. JL revised the draft critically for important 
intellectual content.
REFERENCES
[1] Baert, F., Wouters, K., D’Haens, G., Hoang, P., Naegels, S., 
D'Heygere, F., . . . Geboes, K. (1999). Lymphocytic colitis: 
a distinct clinical entity? A clinicopathological confrontation 
of lymphocytic and collagenous colitis. Gut, 45(3), 375-381.
http://www.ncbi.nlm.nih.gov/pubmed/10446105
[2] Bohr, J., Tysk, C., Eriksson, S., Abrahamsson, H., & 
Jarnerot, G. (1996). Collagenous colitis: A retrospective 
study of clinical presentation and treatment in 163 patients. 
Gut, 39(6), 846-851. http://www.ncbi.nlm.nih.gov/
pubmed/9038667
[3] Brown,  W.  R. ,  & Tayal ,  S .  (2013) .  Microscopic 
colitis.  A review. J Dig Dis,  14(6),  277-281. doi: 
10.1111/1751-2980.12046. http://www.ncbi.nlm.nih.gov/
pubmed/23419063
[4] Chandratre, S., Bramble, M. G., Cooke, W. M., & Jones, R. 
A. (1987). Simultaneous occurrence of collagenous colitis 
and Crohn’s disease. Digestion, 36(1), 55-60. http://www.
ncbi.nlm.nih.gov/pubmed/3556805
[5] Chutkan, R., Sternthal, M., & Janowitz, H. D. (2000). 
A family with collagenous colitis, ulcerative colitis, and 
Crohn’s disease. Am J Gastroenterol, 95(12), 3640-3641. 
doi: 10.1111/j.1572-0241.2000.03388.x.http://www.ncbi.
nlm.nih.gov/pubmed/11151908
[6] Giardiello, F. M., Jackson, F. W., & Lazenby, A. J. (1991). 
Metachronous occurrence of collagenous colitis and 
ulcerative colitis. Gut, 32(4), 447-449. http://www.ncbi.nlm.
nih.gov/pubmed/2026344
[7] Goldstein, N. S., & Gyorfi, T. (1999). Focal lymphocytic 
colitis and collagenous colitis: patterns of Crohn’s colitis? 
Am J Surg Pathol, 23(9), 1075-1081. http://www.ncbi.nlm.
nih.gov/pubmed/10478667
[8] Jegadeesan, R., Liu, X., Pagadala, M. R., Gutierrez, N., 
Butt, M., & Navaneethan, U. (2013). Microscopic colitis: 
is it a spectrum of inflammatory bowel disease? World J 
Gastroenterol, 19(26), 4252-4256. doi: 10.3748/wjg.v19.
i26.4252. http://www.ncbi.nlm.nih.gov/pubmed/23864791
[9] Knights, D., Lassen, K. G., & Xavier, R. J. (2013). Advances 
in inflammatory bowel disease pathogenesis: linking host 
genetics and the microbiome. Gut, 62(10), 1505-1510. doi: 
10.1136/gutjnl-2012-303954. http://www.ncbi.nlm.nih.gov/
pubmed/24037875
[10] Kugathasan, S., & Amre, D. (2006). Inflammatory 
bowel disease—environmental modification and genetic 
determinants. Pediatr Clin North Am, 53(4), 727-749. doi: 
10.1016/j.pcl.2006.05.009. http://www.ncbi.nlm.nih.gov/
pubmed/16873002
[11] Pascua, M. F., Kedia, P., Weiner, M. G., Holmes, J., 
Ellenberg, J., & Lewis, J. D. (2010). Microscopic colitis and 
Medication Use. Clin Med Insights Gastroenterol, 2010(3), 
11-19. http://www.ncbi.nlm.nih.gov/pubmed/20640056
[12] Pokorny, C. S., Kneale, K. L., & Henderson, C. J. (2001). 
Progression of collagenous colitis to ulcerative colitis. J 
Clin Gastroenterol, 32(5), 435-438. http://www.ncbi.nlm.
nih.gov/pubmed/11319318
[13] Vigren, L., Sjoberg, K., Benoni, C., Tysk, C., Bohr, J., 
Kilander, A., . . . Hjortswang, H. (2011). Is smoking a 
risk factor for collagenous colitis? Scand J Gastroenterol, 
46(11), 1334-1339. doi: 10.3109/00365521.2011.610005.
http://www.ncbi.nlm.nih.gov/pubmed/21854096
[14] Villanacci, V., Casella, G., & Bassotti, G. (2011). The 
spectrum of drug-related colitides: important entities, though 
frequently overlooked. Dig Liver Dis, 43(7), 523-528. doi: 
10.1016/j.dld.2010.12.016. http://www.ncbi.nlm.nih.gov/
pubmed/21324756
[15] Xavier, R. J., & Podolsky, D. K. (2007). Unravelling the 
pathogenesis of inflammatory bowel disease. Nature, 
448(7152), 427-434. doi: 10.1038/nature06005. http://www.
ncbi.nlm.nih.gov/pubmed/17653185
